Bacteria fromthe Vibriogenus are autochthonous to aquatic environments and ubiquitous in aquaculture production systems. Many Vibrio species are non-pathogenic and can be commonly found in healthy farmed aquatic animals. However, some Vibrio species and strains are pathogenic leading to a variety of 'vibriosis' diseases. These diseases can have a significant negative impact on animal production, including farmed crustaceans such as shrimps, lobsters, and crabs. As such, vibriosis can pose a threat to meeting growing food demand and global food security. Preventive management is essential to avoid the onset of vibriosis. This includes a robust health management plan, the use of prophylaxis and treatment measures, and enhancing animal health through nutrition. Furthermore, the use of probiotics, prebiotics, synbiotics, quorum sensing disruption, green water, biofloc, bacteriophages, and immune priming could also play a role in preventing and controlling a vibriosis outbreak. This review aims to inform and update the reader about the current state of knowledge about Vibrio and associated vibriosis in farmed crustaceans (i.e. shrimp, lobster, and crabs). Furthermore, the review will identify potential knowledge gaps in the literature, which serves as a basis for future research priorities.

Increased food demand, reflecting a rising global human population, attaining 8 billion in 2022, has furthered the intensification of farmed aquatic animal production. Intensification practices can be resource demanding for micro and macronutrients, dedicated feeds, fossil fuels, chemotherapeutics, and water. Water replaces evaporative losses and may be used to dilute nutrient‐rich wastewater. As an alternative to wastewater discharge, biofloc technology (BFT) uses microbes to manage nutrient levels in production systems. A microbial community grown at high densities can assimilate waste metabolites for growth. This is promoted by increasing the carbon–nitrogen (C:N) ratio using a combination of aquafeed fed to the fish and an additional carbohydrate source, for example, starch, molasses, or bran. The microbial biomass offers a continuous and additional food source to the farmed animal, thus reducing the need for finished aquafeeds and lowering the feed conversion ratio. Although the approach relies on multiple interacting species, BFT can be deployed in relatively low technology settings. This review considers the basis of BFT and identifies areas for innovation and expansion. For example, control of light quantity and quality can influence the biofloc and hence the growth of cultured species. Research on biofloc aquaculture is dominated by studies using tilapia and shrimp, but the technology could be applied to other species, particularly species that are tolerant of biofloc conditions and not highly carnivorous. Biofloc may be a useful biosecurity tool for all or part of the life cycle, and meals made from dried biofloc may enhance the production of cultured species. The key benefits of BFT can potentially be seen in reduced water consumption, lower feed requirements, and improved fish health. This review differs from current review papers in proposing the use of a life cycle assessment in conjunction with BFT, which may be a useful tool for describing and communicating the relative benefits of biofloc systems and their wider environmental impact. This study will serve as a useful knowledge base of BFT information for students, researchers, and stakeholders alike, offering a central source of the main aspects around the culturing of biofloc, key parameters, common species used, areas of potential improvement, and a discussion on where the future of BFT may lie.

• Decapods have nociceptive response and can also experience pain and distress. • General anaesthesia produces analgesia, immobility, and unconsciousness. • Decapods commonly are anaesthetised via injection or anaesthetic bath. • Sedation is used for mild procedures, e.g., transportation. • Decapods’ right to be free of pain must be safeguarded.

A framework for studying sentience in decapods is of great value, but how high a cost (in suffering) to each individual decapod (or any animal) is warranted for collecting scientific evidence of sentience? The lack of evidence for some of the target article’s proposed criteria surely results from the fact that research is focused mainly on biomedical studies, ecotoxicology, and commercial production, with decapod sentience and welfare seen as only a secondary research topic. I draw attention also to the possibility of a wider framework that includes all felt experiences, from suffering to pleasure.